Skip to main content
OpenTrials
Completed

NCT Number: NCT06935058

Effectiveness of Chocolate Milk in Recovery Among Highly Trained Kayakers: A Metabolic and Inflammatory Perspectives

Kayaking requires high energy expenditure and optimal metabolic adaptation for performance and recovery. While research on other sports exists, the effects of chocolate milk on kayakers' recovery remain unexplored.

Intensive kayaking induces physical stress, necessitating precise energy balance monitoring. This study evaluates metabolic and inflammatory markers, including glucose, glycogen, insulin, creatine kinase (CK), interleukin-6 (IL-6), ghrelin, leptin, peptide YY, peripheral blood morphology, and blood gas parameters to assess fatigue and recovery.

Chocolate milk, with its ideal carbohydrate-to-protein ratio, supports glycogen replenishment, muscle repair, hydration, and oxidative stress reduction. Studies suggest it may outperform commercial sports drinks in endurance recovery by limiting muscle damage, inflammation, and improving acid-base balance.

Findings will reveal whether chocolate milk enhances energy recovery, reduces muscle damage, and mitigates inflammation, contributing to endurance sports nutrition strategies

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–22 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Poznań University of Physical Education, Faculty of Physical Culture in Gorzów Wielkopolski

Gorzów Wielkopolski, Polska, 66-400, Poland

About this study

Kayaking, as an endurance discipline, is associated with high energy expenditure and the need to optimize metabolic and hormonal processes in order to maximize efficiency and effective regeneration. Intense physical effort leads to significant changes in muscle metabolism and triggers an inflammatory response in the body. Such large loads require precise monitoring of energy balance and effective regeneration strategies. In the context of such intensive activity, monitoring biochemical indicators becomes crucial. They will allow for the assessment of the degree of fatigue and the course of regeneration processes. As part of the project, key metabolic and inflammatory indicators will be analyzed, such as glucose, glycogen and insulin levels, which will allow for the assessment of the efficiency of energy resource management. In addition, muscle damage indicators will be monitored, such as creatine kinase (CK) and interleukin 6 (IL-6), which will allow for the assessment of fatigue and regeneration processes in athletes.

Acid-base balance, a crucial factor in buffering lactic acid and oxygen transport to muscles, will be analyzed via blood gasometry (ABG). Lactic acid (LA) levels will also be monitored as a key fatigue indicator. Blood morphology analysis will complement the study, assessing the impact of intense exercise and recovery strategies on the hematopoietic and immune systems.

Chocolate milk is increasingly recognized as an effective recovery drink due to its optimal carbohydrate-to-protein ratio (approximately 3:1 or 4:1), promoting rapid glycogen replenishment and muscle fiber repair. Studies suggest that post-exercise chocolate milk consumption may be as effective, or even superior, to commercial sports drinks, particularly in endurance recovery. Additionally, chocolate milk provides high-quality milk protein, electrolytes (calcium, potassium, sodium), and lipids, supporting hydration homeostasis and reducing oxidative stress post-exercise. This combination may limit muscle damage, reduce inflammation (lower CK and IL-6 levels), and improve acid-base balance, making chocolate milk a viable nutritional strategy for endurance athletes.

This study aims to evaluate the effectiveness of chocolate milk in kayakers' recovery by analyzing metabolic, inflammatory, and hematological markers, thus determining its potential role in optimizing endurance sports nutrition strategies.

Changes in glucose, glycogen, insulin, CK, IL-6, grhelin, leptin, peptide YY, peripheral blood morphology, and blood gas parameters will be analyzed to better understand recovery and adaptation mechanisms influenced by chocolate milk consumption. Also, the project results may provide a basis for further research on the role of appetite hormones in sports recovery, which is a relatively new area of research in sports dietetics, and have a significant impact on new strategies to support athletes' performance.

Methods This study will examine chocolate milk's effectiveness in 30 elite kayakers (both sexes), split into experimental (n=15, chocolate milk) and control (n=15, water) groups. Blood samples (capillary and venous) will be collected at three time points: before exercise, immediately after exercise, and 1 hour post-consumption.

  • Experimental group - up to 30 minutes after the erometer test, consumes 400 ml of chocolate milk.

Control group - up to 30 minutes after the erometer test, consumes 400 ml of water.

  • Exercise test: During the preparatory period (April/May), participants will perform an intensive exercise test on a kayak ergometer (Dansprint PRO, Denmark), consisting of covering a distance of 1000 meters in the shortest time possible. The kayak ergometer test will be performed under medical supervision.
  • Before the exercise test, a non-invasive anthropometric analysis will be performed using the TANITA MC-780MA body composition analyzer (Tokyo, Japan), to determine body composition: percentage of body fat, body fat mass, lean tissue mass, muscle mass, water and body mass index (BMI).
  • Before the ergometer test, a nutrition analysis will be performed using the food diary method.
  • Before the exercise test, a meal will be served containing a standardized amount of kcal, protein, fat, carbohydrates and fiber, calculated per kg of the athlete's body weight, in accordance with the nutrition standards for the Polish population edited by Mirosław Jarosz and the recommendations of the International Society of Sports Nutrition.
  • During the test, measurements will be taken: travel time, average power, heart rate.

The results will determine whether chocolate milk accelerates energy replenishment, reduces muscle damage, and decreases inflammation compared to water consumption. This research will contribute to optimizing endurance sports nutrition strategies and serve as a basis for further studies on recovery methods.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lack of consent for blood sampling,
  • injuries, health issues,
  • anti-inflammatory drugs,
  • performance-enhancing substances,
  • supplements within the last 3 months before the start of the study.

Exclusion criteria

  • consent to participate in the study,
  • regular training regimen,
  • current medical examinations,
  • no health contraindications.

Treatment and study plan

Chocolade milk

Other

Participants will drink 400 ml of chocolate milk after exercise.

Water (Placebo)

Other

Participants will drink 400 ml of water after exercise.

Primary outcomes

  1. Changes from baseline in Glycogen level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of glycogen [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit

  2. Changes from baseline Insulin level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption..

    Concentration of insulin [μIU/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit

  3. Changes from baseline Creatine kinase activity (CK) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concetration of CK [ng/ml]. Immunoenzymatic assay method using a diagnostic ELISA Kit

  4. Changes from baseline interleukin-6 (Il-6) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of Il-6 [pg/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit

  5. Changes from baseline in lactic acid (LA) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concetration of LA [mmol/l]. Using a portable biochemical photometer Vario Photometer II (Diaglobal, Berlin, Germany) (capillary blood from the ear lobe).

  6. Baseline Appetite Assessment of Athletes Before Exercise Test Using Visual Analogue Scale (VAS).

    Time frame: Day 1: At rest, after the exercise test.

    The Visual Analogue Scale (VAS) measures subjective appetite sensations-linear scale from one to 10 where 10 is the strongest feeling.

  7. Changes from baseline in leptin (LEP) level.

    Time frame: Day 1:At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Satiety regulation marker. Concentration of leptin [pg/ml].ELISA method by the test manufacturer's instructions.

  8. Changes from baseline in peptide YY (PYY) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Satiety regulation marker. Concentration of leptin [pg/ml]. ELISA method by the test manufacturer's instructions.

  9. Changes from baseline in ghrelin (GHRL) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Hunger regulation marker. Concentration of GHRL [pg/ml].ELISA method by the test manufacturer's instructions.

  10. Changes from baseline in acid-base balance - urea nitrogen (BUN) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of BUN [ml/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  11. Changes from baseline in acid-base balance - anion gap (AGAP) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of AGAP [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  12. Changes from baseline in acid-base balance - excess base in extracellular fluid (BE ecf) level.

    Time frame: Day1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of Be ecf [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  13. Changes from baseline in acid-base balance - sodium (Na) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of Na [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  14. Changes from baseline in acid-base balance - calcium (Ca) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of Ca [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  15. Changes from baseline in acid-base balance - potassium (K) level

    Time frame: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of K [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  16. Changes from baseline in acid-base balance - chlorine (Cl) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of Cl [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  17. Changes from baseline in acid-base balance - bicarbonate level (cHCO3).

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of cHCO3 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  18. Changes from baseline in acid-base balance - total plasma CO2 (tCO2) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of tCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  19. Changes from baseline in acid-base balance - partial pressure of carbon dioxide (pCO2)

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of pCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  20. Changes from baseline in acid-base balance - partial pressure of oxygen (pO2)

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of pO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  21. Changes from baseline in acid-base balance -total blood saturation (cSO2) level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of cSO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  22. Changes from baseline in acid-base balance - urea level.

    Time frame: Day 1:At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of urea [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  23. Changes from baseline in acid-base balance - crea level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of crea [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  24. Changes from baseline in acid-base balance - hematocrit [hct] level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of hct [%]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  25. Changes from baseline in acid-base balance - hemoglobin [chgb] level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of chgb [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

  26. Changes from baseline in acid-base balance - glucose [glu] level.

    Time frame: Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    Concentration of glu [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

Secondary outcomes

  1. Antropometric characteristic - height

    Time frame: Day 1 after overall fast

    Prior to the exercise test, we measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) [cm]

  2. Antropometric characteristic - weight

    Time frame: Day 1 after overall fast

    Anthropometric characteristic - weight

  3. Antropometric characteristic - LBM

    Time frame: Day 1 after overall fast

    Prior to the exercise test, we measured the anthropometric parameters, including lean body mas (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]

  4. Antropometric characteristic - TBW

    Time frame: Day 1 after overall fast

    Prior to the exercise test, we measured the anthropometric parameters, including total body water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]

  5. Antropometric characteristic - Water%

    Time frame: Day 1 after overall fast

    Prior to the exercise test, we measured the anthropometric parameters, including water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%]

  6. Antropometric characteristic - FAT

    Time frame: Day 1 after overall fast

    Prior to the exercise test, we measured the anthropometric parameters, including fat (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%]

  7. Food record - energy

    Time frame: Day before the Day 1

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: energy [kcal]

  8. Food record - protein

    Time frame: Day before the Day 1

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: protein [g]

  9. Food record - carobhydrates

    Time frame: Day before the Day 1

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: carbohydrates [g]

  10. Food record - fiber

    Time frame: Day before the Day 1

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: fiber [g]

  11. Food record - fat

    Time frame: Day before the Day 1

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: fat [g]

  12. Peripheral blood morphology

    Time frame: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

    using MYTHIC18 hematology analyzer (Cormay Diagnostics, Geneva, Switzerland). Qualitative and quantitative evaluation of morphological elements of blood (determination in venous blood).

Sponsors and collaborators

Lead sponsor

Poznan University of Physical Education

Other

Registry information

Official study title

Effectiveness of Chocolate Milk in Recovery Among Elite Kayakers: A Metabolic and Inflammatory Perspectives

Acronym: Kayakers2025

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 18, 2025
Registry last updated
Nov 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.